Vaccines

08 Feb 2010 Nabi Biopharmaceuticals Completes Another PentaStaph(TM) Milestone
08 Feb 2010 Inovio Biomedical Cervical Cancer Therapeutic Vaccine Generates Dose-Related Immune Response in Clinical Trial
08 Feb 2010 Dynavax Initiates Large-Scale Phase 3 Trial of HEPLISAV(TM)
02 Feb 2010 Soligenix Announces Publication of Positive Stability Results with RiVax(TM), its Vaccine Against Ricin Toxin
01 Feb 2010 FIRST TREATMENT TO IMPROVE SURVIVAL IN 20 YEARS NOW AVAILABLE FOR PATIENTS WITH OSTEOSARCOMA (BONE CANCER)
31 Jan 2010 Bill and Melinda Gates Pledge $10 Billion in Call for Decade of Vaccines
28 Jan 2010 Vical Completes Enrollment in Allovectin-7(r) Phase 3 Trial for Metastatic Melanoma
20 Jan 2010 New Study Shows ImmunoCellular Therapeutics' Lead Investigational Cancer Vaccine ICT-107 Targets Cancer Stem Cells
19 Jan 2010 Circassia Extends its Clinical-Stage Portfolio With Phase II Trials of T-cell Vaccines Against House Dust Mite and Cat Allergies
19 Jan 2010 Mymetics Corporation: The First Human Vaccinations of Mymetics' Preventative HIV Vaccine Candidate are Well Tolerated
15 Jan 2010 International Medica Foundation Reaches Final Vaccination Milestone in Phase II Clinical Trial for Rotavirus Vaccine
13 Jan 2010 Start of Phase II Study for Intranasal, Seasonal Influenza Vaccine deltaFLU AVIR Green Hills Biotechnology AG
13 Jan 2010 Xcellerex Initiates Phase I Clinical Trial of Novel Yellow Fever Vaccine
12 Jan 2010 NOVAVAX Announces Positive Preclinical Results for its Respiratory Syncytial Virus (RSV) Vaccine Candidate
11 Jan 2010 Inhibitex Provides Update on Its Staph Vaccine, FV-100 and INX-189 Development Programs
07 Jan 2010 Mechanism of Action for Vical's Vaxfectin(R) Adjuvant Expands Potential Applications
07 Jan 2010 Hawaii Biotech Completes Dosing of Phase 1 Trial for Dengue Virus Monovalent Vaccine
04 Jan 2010 Intercell starts an additional efficacy trial for its patch-based investigational Travelers’ Diarrhea Vaccine System in Asia
30 Dec 2009 Pfizer Provides U.S. Regulatory Update On Prevnar 13™ Vaccine
29 Dec 2009 Fifteen Percent of ADXS11-001 Treated Cervix Cancer Patients Still Alive Three Years after Initial Dosing
29 Dec 2009 Vical Confirms Advantages of DNA Technology Platform With Vaccine for H1N1 Influenza
28 Dec 2009 Soligenix Announces Publication of Positive Pre-Clinical Results with RiVax(TM), Its Vaccine Against Ricin Toxin
28 Dec 2009 Vical's Allovectin-7(R) Phase 3 Trial Receives Positive Review From Safety Monitoring Board
28 Dec 2009 Intercell announces initiation in the U.S. of a Phase III study for vaccine to protect children against Japanese Encephalitis
21 Dec 2009 All three Novartis A(H1N1) 2009 influenza vaccines prequalified by World Health Organization (WHO) for use in developing world

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2019 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up

Top